3SBIO (01530) received a chief financial officer's cumulative increase in holdings of a total of 3 million shares.

3SBIO (01530) announced that the Chief Financial Officer, He Xiang, has reported that from January 1, 2024 to the date of this announcement, the company has purchased a total of 3 million ordinary shares through centralized bidding at an average price of approximately HK$5.99 per share, representing approximately 0.12% of the total issued shares. He Xiang informed the board that he believes the shares are undervalued in the long term, and based on his confidence in the company's business and prospects, he intends to further increase his stake in the company based on market conditions and subject to applicable laws and regulations. He Xiang confirmed to the board that he was not aware of any insider information regarding the company when purchasing the shares. The increase in shareholding mentioned in this announcement was voluntary on the part of the Chief Financial Officer.